Anti-Endothelial Cell Antibodies (AECA) in Systemic Sclerosis - Increased Sensitivity using Different Endothelial Cell Substrates and Association with Other Autoantibodies

References

• Prescott RJ, Freemont AJ, Jones CJP, Hoyland J, Fielding P. Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol 1992; 166: 255–63
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y, Isenberg DA. The mosaic of autoimmunity. Elsevier, The Netherlands 1989; 1–520
   Google Scholar
• Luderschmidt C. Diagnostische und prognostishe parameter dcr progressiven Systemischen Sklerodermie. Akiuelle Rheumatologie 1996; 21: 171–7
   Google Scholar
• Rosenbaum J, Pottinger BE, Woo P, Black CM, Loizou S, Byron MA. Measurement and characterization of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol 1988; 72: 450–6
   PubMed Web of Science ®Google Scholar
• Salojin KV, Le Tonqueze M., Saraux A, Nassonov EL, Dueymes M, Piette JC. Antiendothelial cell antibodies: useful markers of systemic sclerosis. Am J Med 1997; 102: 178–85
   PubMed Web of Science ®Google Scholar
• Sgonc R, Gruschwitz MS, Dietrich H, Recheis H, Gershwin ME, Wick G. Endothelial cell apoptosis is a primary pathogenic event underlying skin lesions in avian and human scleroderma. J Clin invest 1996; 98: 785–92
   PubMed Web of Science ®Google Scholar
• Carvalho D, Savage COS, Black CM, Pearson JD. IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. J Clin invest 1996; 97: 111–9
   PubMed Web of Science ®Google Scholar
• Meroni PL., Youinou P. Endothelial cell autoantibodies. Autoantibodies, JB Peter, Y. Shoenfeld. Elsevier Science, The Netherlands 1996; 245–52
   Google Scholar
• Subcommittee for scleroderma criteria of the American Rheumatism Association. Diagnostic and therapeutic criteria. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581–90
   PubMed Web of Science ®Google Scholar
• Maricq HR, Weinrich MC, Keil JE, Smith EA, Harper FE, Nussbaum AL, Le Roy EC. Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 1989; 32: 998–1006
   PubMed Web of Science ®Google Scholar
• Jaffe EA, Hoyer RW, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973; 52: 2757–64
   PubMed Web of Science ®Google Scholar
• Liu ZY, Gam'u RK, Wang JF, Schweitzer K, Weksler B, Avra-Ham S, Groopman JE. Characterization of signal transduction pathways in human bone marrow endothelial cells. Blood 1997; 90: 2253–9
   PubMed Web of Science ®Google Scholar
• Flore O, Rafii S, Ely S, O'Leary JJ, Hyjek EM, Cesarman E. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpes virus. Nature 1997; 394: 588–92
   Web of Science ®Google Scholar
• Edgell CJS, McDonald CC, Graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl AeadSci USA 1983; 80: 3734–7
   PubMed Web of Science ®Google Scholar
• Le Tonqueze M, Jamin C, Bohme M, Le Corre R., Dueymes M, Youinou P. Establishment and characterization of permanent human endothelial cell clones. Lupus 1996; 5: 103–12
   PubMed Web of Science ®Google Scholar
• Blank M, Krause I, Ben-Bassat M, Shoenfeld Y. Induction of antiphospholipid associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotjjpe. J Autoimmunity 1992; 5: 495–509
   PubMed Web of Science ®Google Scholar
• Suenaga R, Abdou NH. Heparan sulfate-ELISA gives false positive results for anti DNA-DNA/histone immune complexes in sera of patients with SLE. Lupus 1995; 4: 57–62
   PubMed Web of Science ®Google Scholar
• Renaudineau Y, Revelen R, Bordron A, Mottier DP, Le Corre R. Two populations of endothelial cell antibodies cross-react with heparin. Lupus 1998; 7: 86–94
   PubMed Web of Science ®Google Scholar
• Zurgil N, Bakimer R, Moutsopoulos HM, T/ioufas AG, Youinou P, Isenberg DA. Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases. J Clin Immunol 1992; 12: 201–9
   PubMed Web of Science ®Google Scholar
• Pettit FH, Reed LJ. Pyruvate dehydrogenase complex from bovine kidney and heart. Methods Enzymol 1982; 89: 376–86
   PubMed Web of Science ®Google Scholar
• Renaudineau Y, Revelen R, Levy Y, Salojin K, Gilburd B, Shoenfeld Y, Youinou P. Antiendothelial cell antibodies in systemic sclerosis. Clin Diagn Lab Immunol 1999; 6: 156–60
   PubMedGoogle Scholar
• Fillit H, Labita R. Antibodies to vascular heparan sulfate proteoglycan in patients with systemic lupus erythematosus. Autoimmunity 1991; 9: 159–64
   PubMed Web of Science ®Google Scholar
• McHugh NJ, James IE, Fairbum K, Maddison PJ. Autoantibodies to mitochondrial and centromer antigens in primary biliary cirrhosis and systemic sclerosis. Clin Exp Immunol 1990; 81: 244–9
   PubMed Web of Science ®Google Scholar
• Tsuneyania K, van de Water J, Leung PS, Cha S, Nakanuma Y, Kaplan M. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression. Hepatology 1995; 21: 1031–7
   PubMed Web of Science ®Google Scholar
• Mattalia A, Quaranta S, Leung PSC, Bauducci M, van de Water J, Calvo PL. Characterization of antimitochondrial antibodies in healthy adults. Hepatology 1998; 27: 656–61
   PubMed Web of Science ®Google Scholar
• Whyte J, Hough D, Maddison PJ, McHugh NJ. The association of primary biliary cirrhosis and systemic sclerosis is not accounted for by cross reactivity between mitochondrial and centromere antigens. J Autoimmun 1994; 7: 413–24
   PubMed Web of Science ®Google Scholar
• Tincani A, Meroni PL, Brucato A, Zanussi C, Allegri F, Mantelli P. Anti-phospholipid and anti-mitochondrial type M5 antibodies in SLE. Clin Exp Rheumatic 1985; 3: 321–4
   PubMedGoogle Scholar
• Yasoshima M, Nakanuma Y, Tsuneyama K, van de Water J, Gershwin ME. Immunohistochemical analysis of adhesion molecules in the micro-environment of portal tracts in relation to aberrant expression of PDC-E2 and HLA-DR on the bile ducts in primary biliary cirrhosis. J Pathol 1995; 175: 319–25
   PubMed Web of Science ®Google Scholar